Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. 10 stocks we like ...

Eli Lilly's share price now stands above $1,000. The company's outlook through the next few years seems strong. The pharma giant looks likely to conduct a stock split in the (relatively) near future.

Stock splits bring in new investors in. Netflix, just days away from splitting, is the latest. We think Eli Lilly is next—and that could mean gains for the stock.

Stock splits may not alter a company's fundamentals, but keeping an eye on stocks that are likely to experience a split could be a profitable move. Dutch semiconductor manufacturing equipment maker ...

Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for their promise of steady gains over the ...